Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Mcmillan Shakespeare Limited ( (AU:MMS) ).
McMillan Shakespeare Limited has released a presentation outlining its 1HFY26 results, noting that the document is a high-level summary of the group’s performance and activities as at 23 February 2026. The company emphasises that the material is informational only, is not investment advice or an offer of securities, and that any forward-looking statements are subject to significant risks and uncertainties, with no assurance given on their accuracy or future outcomes.
The most recent analyst rating on (AU:MMS) stock is a Buy with a A$21.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
More about Mcmillan Shakespeare Limited
McMillan Shakespeare Limited is an Australian-listed company that provides financial and salary packaging services through its subsidiaries. The group operates in the broader financial services sector, with a focus on employee benefits administration and related corporate solutions for clients across Australia.
YTD Price Performance: 2.29%
Average Trading Volume: 154,138
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$1.21B
See more data about MMS stock on TipRanks’ Stock Analysis page.